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A 45-year-old man had a past history of psoriasis and pulmo-
nary tuberculosis with postantituberculosis treatment status. Pso-
riasis was diagnosed from typical clinical presentation and
histopathology ﬁndings. He received irregular treatment with
oral methotrexate and topical steroids for psoriasis. The patient
was admitted for inpatient treatment because of severe sepsis
and erythrodermic psoriasis (Figure 1). However, he developed
multiple severe painful ulcerations on the abdomen, back, and but-
tocks for 3 days. Some preceding itchy erythematous papules were
noted on the lower abdomen 2 days before this episode. No obvious
herpes labialis, herpes genitalis, or herpes zoster infection were
found.
On physical examination, he had widespread and progressive
clusters of painful punched-out ulcerations on the abdomen,
back, and buttocks (Figure 2A and C). Tzanck smear from the ba-
ses of these lesions tested positive for multinucleated giant cells
and keratinocytes with ballooning change (Figure 2B). We also
performed a skin biopsy of the erythroderma to rule out other
possibilities; the histopathological diagnosis was psoriasis. In
addition, multiple hyperkeratotic papuloplaques and excoriations
were noted on the interdigital folds of the hands and bilateralFigure 1 Generalized scaly erythematous patches and plaques on the face, trunk, and
limbs.
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examination revealed the presence of scabies mites, and the le-
sions were diagnosed as scabies infestation. The patient was
started on a regimen of parenteral acyclovir sodium (Zovirax
250 mg, 3 times daily for 14 days), parenteral teicoplanin (Targo-
cid 400 mg daily for 14 days) for methicillin-resistant Staphylo-
coccus aureus bacterial infection, and oral ivermectin
(Stromectol 12 mg once and repeated at Day 14) for scabies infes-
tation. Topical silver sulfadiazine cream twice a day was used for
wound care. There were signiﬁcant re-epithelialization and heal-
ing after the treatment.
Kaposi's varicelliform eruption (KVE), ﬁrst described by Moritz
Kaposi in 1887, is awidespread cutaneous infectionwith herpesvirus
type 1 or type2, vacciniavirus, or coxsackievirus A16 in a patientwith
underlying dermatoses.1 The term “eczema herpeticum” is used if
herpesvirus type 1 or type 2 is the causative pathogen. KVE is most
often seen in patients with underlying atopic dermatitis. In addition,
multiple underlying dermatoses associated with KVE have been re-
ported, including pemphigus foliaceous, Darier disease, pemphigus
vulgaris, pityriasis rubra pilaris, Hailey-Hailey disease, irritant con-
tact dermatitis, cutaneous T-cell lymphoma, seborrheic dermatitis,
Wiskott-Aldrich syndrome, congenital icthyosiform erythroderma,
and Sezary syndrome.2e4 However, KVE rarely occurs in psoriasis
and only a few cases have been reviewed in literature. In 2002, Saras-
wat et al ﬁrst described KVE in a patient with erythrodermic psoria-
sis.5 The term “psoriasis herpeticum” was coined by Santmyire-
Rosenberger et al to describe the occurrence of KVE in psoriasis.6
KVE may begin as painful vesiculopustular, sometimes umbili-
cated, lesions which then progress to punched-out ulcerations in
the area affected by the underlying dermatoses. The lesions most
commonly appear on the face and often spread in 7e10 days.7
The lesions may coalesce into large, ulcerated, painful plaques
that can be easily superinfected with bacteria and yeast.8 KVE can
be associated with fever, malaise, and lymphadenopathy. The
average duration of KVE has been estimated to be 16 days, and le-
sions most often heal without scarring in 2e6 weeks.8
Risk factors for KVE reported in literature include erythroderma,
systemic sepsis, therapy with immunosuppressants such as metho-
trexate and systemic steroids, and therapy with systemic retinoids.6
In a case series, erythroderma was noted in 35% of patients with
KVE. The underlying dermatoses for KVE with erythroderma
included airborne contact dermatitis (15%), psoriasis (15%), and
cutaneous T-cell lymphoma (5%).9 In the present case, the patient
concurrently suffered from a scabies infestation. However, scabies
infestation associated severe itching, excoriation, and broken skinnﬂicts of interest related to the subject matter or materials discussed in this article.
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Figure 2 (A) (C) Widespread and progressive clusters of painful punched-out ulcera-
tions on the abdomen, back, and buttocks; (B) Tzanck smears of these lesions were
positive for multinucleated giant cells and keratinocyte with ballooning change (yel-
low arrows). (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)
Correspondence / Dermatologica Sinica 33 (2015) 247e248248barrier may increase susceptibility to KVE. We thus suspect that
concurrent scabies infestation may also be a risk factor for KVE.
The differential diagnosis of KVE includes impetigo, irritant
contact dermatitis, and chemical corrosive injury. Physical exam-
ination, laboratory testing, and careful recording of the patient's
history will aid diagnosis. A Tzanck smear, microscopically
showing the presence of multinucleated giant cells and keratino-
cytes with ballooning change, can conﬁrm the presence of a viral
infection. Direct immunoﬂuorescence which provides more sen-
sitive and speciﬁc results using unique herpes virus antibodies
can be performed in a specialized laboratory. Viral cultures can
also help to conﬁrm the diagnosis of KVE, but it takes several
days.4
Immediate antiviral therapy is essential in patients with KVE.
Intravenous acyclovir (10e15 mg/kg/day) and oral acyclovirwere deemed effective.7 If superinfection with bacteria and yeast
occur, treatment with antibiotics and an antifungal agent is
necessary.
Psoriasis herpeticum due to varicella zoster virus (VZV) has been
reported recently.10 KVE with prominent herpetiform segmental
vesiculopustular eruptions favor the diagnosis of VZV-related pso-
riasis herpeticum. Comparing our case with that describing VZV-
related psoriasis herpeticum,10 both reports describe patients
who were febrile, erythrodermic, and under immunosuppressive
therapy. However, we found neither zosteriform distribution nor
disseminated lesions in our patient. Both cases responded well to
acyclovir therapy.
Here, we reported a rare case of psoriasis herpeticum, KVE, in a
patient with erythrodermic psoriasis and severe sepsis. Early recog-
nition of KVE in patients with psoriasis, identiﬁcation of the associ-
ated risk factors, and early initiation of antiviral therapy will lead to
a better prognosis in such patients.
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